Artículos del autor

solaci

Acute coronary syndromes

Optimal Intervention Timing for NSTEMI with No Antiaggregant Pre-Treatment

Patients undergoing non-ST elevation MI (NSTEMI) who are not pre-treated with P2Y12 receptor inhibitors will benefit from...
solaci -
Nurses and Technicians Articles

Webinar SOLACI | Cath Lab Management During the COVID-19 Pandemic. Latin American Perspective

Watch again our Webinar on Cath Lab Management During the COVID-19 Pandemic. Latin American Perspective.  The event was...
solaci -
Acute coronary syndromes

Multiple vs. Culprit vessel MI in Cardiogenic Shock: Anything New?

The Shock Trial, the one that set revascularization as the standard strategy to treat all STEMI and...
solaci -
Coronary disease

Estimating the Risk of Infection for Healthcare Personnel

Roughly one out of every 100 healthcare workers at hospitals receiving COVID-19 patients become infected. Statistics are not...
solaci -
Institutional News

SOLACI Peripheral | Clinical Case Discussion

SOLACI’s Department of Peripheral Endovascular Interventions is promoting the analysis of challenging clinical cases on peripheral interventions...
solaci -
Acute coronary syndromes

Compare-Acute Sub-Study: Natural History of Non-Culprit Lesions in MI

The aim of this study was to determine the prognostic value of fractional flow reserve (FFR) of...
solaci -
Institutional News

SOLACI Webinar – 18/06- Left Main Coronary Artery PCI 360: Clinical Case, Technique and Evidence

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...
solaci -
Acute coronary syndromes

Bleeding and Cardiogenic Shock: An “Unholy Alliance”?

Courtesy of Dr. Carlos Fava. Mortality in acute myocardial infarction (MI) with cardiogenic shock (CS) has been reduced over...
solaci -